24 September, 2010London, UKThe Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as …
IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Valuations are essential components of effective transactions in the life sciences industry
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.
The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …